No Man

Sign in

Join Free
Post RFQ

Ticagrelor Impurity A

TypeName: Business Offer

Category:

Offer Date:2019/08/10

Country: United States

Summary: An impurity of Ticagrelor, which is the first reversible oral P2Y12 receptor antagonist and has favorable pharmacokinetics and pharmacodynamics, including rapid peaking of plasma levels (1.5-3 hours) and rapid onset of antiplatelet effects (within 2 hours). https://www.bocsci.com/ticagrelor-impurity-a-cas-1788033-05-5-item-484065.html

Description:

OfferId: 5145

Name:Alex Brown

Telphone:

Email:[email protected]